Functional Implications of the spectrum of BCL2 mutations in Lymphoma.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Mutation research. Reviews in mutation research

• Publication date

  2016-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.mrrev.2016.06.001PMID 27543313
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Small-Molecule Bcl2 BH4 Antagonist for Lung Cancer Therapy.

  2015cited by this paper
• Inhibition of Bcl-2 Sensitizes Mitochondrial Permeability Transition Pore (MPTP) Opening in Ischemia-Damaged Mitochondria

  2015cited by this paper
• Ryanodine receptors are targeted by anti-apoptotic Bcl-XL involving its BH4 domain and Lys87 from its BH3 domain

  2015cited by this paper
• Apoptosis, autophagy, necroptosis, and cancer metastasis

  2015cited by this paper
• BCL2 mutation spectrum in B‐cell non‐Hodgkin lymphomas and patterns associated with evolution of follicular lymphoma

  2015cited by this paper
• Inhibition of Pro-apoptotic BAX by a noncanonical interaction mechanism.

  2015cited by this paper
• BCL2 mutations are associated with increased risk of transformation and shortened survival in follicular lymphoma.

  2015cited by this paper
• Dysregulation of autophagy in human follicular lymphoma is independent of overexpression of BCL-2

  2014cited by this paper
• BCL2 antibodies targeted at different epitopes detect varying levels of protein expression and correlate with frequent gene amplification in diffuse large B-cell lymphoma.

  2014cited by this paper
• Bcl-2 binds to and inhibits ryanodine receptors

  2014cited by this paper
• Novel polymeric nanoparticles for intracellular delivery of peptide Cargos: antitumor efficacy of the BCL-2 conversion peptide NuBCP-9.

  2014cited by this paper
• Acquired mutations in BCL2 family proteins conferring resistance to the BH3 mimetic ABT-199 in lymphoma.

  2014cited by this paper
• Genetics of follicular lymphoma transformation.

  2014cited by this paper
• Integrated strategy reveals the protein interface between cancer targets Bcl-2 and NAF-1

  2014cited by this paper
• The role of angiogenesis in human non-Hodgkin lymphomas.

  2013cited by this paper
• Cancer Genome Landscapes

  2013cited by this paper
• Removal of the BH4 domain from Bcl-2 protein triggers an autophagic process that impairs tumor growth.

  2013cited by this paper
• Dual-site Interactions of p53 Protein Transactivation Domain with Anti-apoptotic Bcl-2 Family Proteins Reveal a Highly Convergent Mechanism of Divergent p53 Pathways*

  2013cited by this paper
• Alpha-Helical Destabilization of the Bcl-2-BH4-Domain Peptide Abolishes Its Ability to Inhibit the IP3 Receptor

  2013cited by this paper
• BH4 domain of bcl-2 protein is required for its proangiogenic function under hypoxic condition.

  2013cited by this paper
• Small Peptides against the Mutant SOD1/Bcl-2 Toxic Mitochondrial Complex Restore Mitochondrial Function and Cell Viability in Mutant SOD1-Mediated ALS

  2013cited by this paper
• Genetic heterogeneity of diffuse large B-cell lymphoma

  2013cited by this paper
• Interaction of Bcl-2 with the Autophagy-related GABAA Receptor-associated Protein (GABARAP)

  2013cited by this paper
• Mutational and structural analysis of diffuse large B-cell lymphoma using whole-genome sequencing.

  2013cited by this paper
• The Natively Disordered Loop of Bcl-2 Undergoes Phosphorylation-Dependent Conformational Change and Interacts with Pin1

  2012cited by this paper
• The FKBP38 Catalytic Domain Binds to Bcl-2 via a Charge-sensitive Loop

  2012cited by this paper
• The BCL-2-Specific BH3-Mimetic ABT-199 (GDC-0199) Is Active and Well-Tolerated in Patients with Relapsed Non-Hodgkin Lymphoma: Interim Results of a Phase I Study

  2012cited by this paper
• Anoikis Resistance: An Essential Prerequisite for Tumor Metastasis

  2012cited by this paper
• BCL2 mutations in diffuse large B-cell lymphoma

  2012cited by this paper
• Targeting the B-cell lymphoma/leukemia 2 family in cancer.

  2012cited by this paper
• Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing

  2012cited by this paper
• The hallmarks of cancer

  2012cited by this paper
• Molecular dynamics simulations of the Bcl-2 protein to predict the structure of its unordered flexible loop domain

  2012cited by this paper
• Hallmarks of cancer: the next generation.

  2011cited by this paper
• Selective regulation of IP3-receptor-mediated Ca2+ signaling and apoptosis by the BH4 domain of Bcl-2 versus Bcl-Xl

  2011cited by this paper
• Involvement of BH4 domain of bcl-2 in the regulation of HIF-1-mediated VEGF expression in hypoxic tumor cells

  2011cited by this paper
• Frequent mutation of histone modifying genes in non-Hodgkin lymphoma

  2011cited by this paper
• BCL2 inhibits Cell Adhesion, Spreading, and Motility by Enhancing Actin Polymerization

  2010cited by this paper
• A method and server for predicting damaging missense mutations

  2010cited by this paper
• ERK1/2 MAP kinases promote cell cycle entry by rapid, kinase-independent disruption of retinoblastoma–lamin A complexes

  2010cited by this paper
• ALS-linked mutant SOD1 damages mitochondria by promoting conformational changes in Bcl-2

  2010cited by this paper
• The importance of natural IgM: scavenger, protector and regulator

  2010cited by this paper
• Pseudonegative BCL2 protein expression in a t(14;18) translocation positive lymphoma cell line: a need for an alternative BCL2 antibody

  2010cited by this paper
• New insights into p53 activation

  2010cited by this paper
• Calcium regulation of mitochondria motility and morphology.

  2009cited by this paper
• Coding-Sequence Determinants of Gene Expression in Escherichia coli

  2009cited by this paper
• The molecular mechanism of mitochondrial fusion.

  2009cited by this paper
• Voltage-dependent Anion Channel 1-based Peptides Interact with Bcl-2 to Prevent Antiapoptotic Activity*

  2009cited by this paper
• BCL6 suppression of BCL2 via Miz1 and its disruption in diffuse large B cell lymphoma

  2009cited by this paper
• The BH4 domain of Bcl-2 inhibits ER calcium release and apoptosis by binding the regulatory and coupling domain of the IP3 receptor

  2009cited by this paper
• The mitochondrial p53 pathway.

  2009cited by this paper
• Mechanism and regulation of class switch recombination.

  2008cited by this paper
• Molecular basis of the regulation of Beclin 1-dependent autophagy by the γ-herpesvirus 68 Bcl-2 homolog M11

  2008cited by this paper
• Targeting Bcl-2-IP3 receptor interaction to reverse Bcl-2's inhibition of apoptotic calcium signals.

  2008cited by this paper
• A short Nur77-derived peptide converts Bcl-2 from a protector to a killer.

  2008cited by this paper
• A "Silent" Polymorphism in the MDR1 Gene Changes Substrate Specificity

  2007cited by this paper
• Functional and physical interaction between Bcl‐XL and a BH3‐like domain in Beclin‐1

  2007cited by this paper
• Moving Mitochondria: Establishing Distribution of an Essential Organelle

  2007cited by this paper
• Crystal Structure of the Bcl-XL-Beclin 1 Peptide Complex

  2007cited by this paper
• Bcl-2 and Bcl-XL regulate proinflammatory caspase-1 activation by interaction with NALP1.

  2007cited by this paper
• Identification of a novel Bcl-2 promoter region that counteracts in a p53-dependent manner the inhibitory P2 region.

  2007cited by this paper
• BH3 profiling identifies three distinct classes of apoptotic blocks to predict response to ABT-737 and conventional chemotherapeutic agents.

  2007cited by this paper
• Patterns of somatic mutation in human cancer genomes

  2007cited by this paper
• BCL2 Is a Downstream Effector of MIZ-1 Essential for Blocking c-MYC-induced Apoptosis*

  2007cited by this paper
• Calcium signalling and cell-fate choice in B cells

  2007cited by this paper
• Mitochondria primed by death signals determine cellular addiction to antiapoptotic BCL-2 family members.

  2006cited by this paper
• Bcl2 Suppresses DNA Repair by Enhancing c-Myc Transcriptional Activity*

  2006cited by this paper
• Protein phosphatase 2A inactivates Bcl2's antiapoptotic function by dephosphorylation and up-regulation of Bcl2-p53 binding.

  2006cited by this paper
• Bcl2's Flexible Loop Domain Regulates p53 Binding and Survival

  2006cited by this paper
• Statistical Analysis of Pathogenicity of Somatic Mutations in Cancer

  2006cited by this paper
• BH3 domains of BH3-only proteins differentially regulate Bax-mediated mitochondrial membrane permeabilization both directly and indirectly.

  2005cited by this paper
• An inhibitor of Bcl-2 family proteins induces regression of solid tumours

  2005cited by this paper
• The flexible loop of Bcl‐2 is required for molecular interaction with immunosuppressant FK‐506 binding protein 38 (FKBP38)

  2005cited by this paper
• PUMA Couples the Nuclear and Cytoplasmic Proapoptotic Function of p53

  2005cited by this paper
• How do follicular dendritic cells interact intimately with B cells in the germinal centre?

  2005cited by this paper
• Interaction of bcl-2 with Paxillin through Its BH4 Domain Is Important during Ureteric Bud Branching*

  2004cited by this paper
• Defining the p53 DNA‐binding domain/Bcl‐xL‐binding interface using NMR

  2004cited by this paper
• Suppression of anoikis and induction of metastasis by the neurotrophic receptor TrkB

  2004cited by this paper
• The first alpha helix of Bax plays a necessary role in its ligand-induced activation by the BH3-only proteins Bid and PUMA.

  2004cited by this paper
• BCL2 translocation defines a unique tumor subset within the germinal center B-cell-like diffuse large B-cell lymphoma.

  2004cited by this paper
• Conversion of Bcl-2 from protector to killer by interaction with nuclear orphan receptor Nur77/TR3.

  2004cited by this paper
• Cloning and Functional Analysis of BAG-l: A Novel Bcl-2-Binding Protein with Anti-Cell Death Activity

  2004cited by this paper
• Modulation of Synaptic Transmission by the BCL-2 Family Protein BCL-xL

  2003cited by this paper
• BH4-domain peptide from Bcl-xL exerts anti-apoptotic activity in vivo

  2003cited by this paper
• Bcl2 retards G1/S cell cycle transition by regulating intracellular ROS.

  2003cited by this paper
• Transcriptional analysis of the B cell germinal center reaction

  2003cited by this paper
• p53 has a direct apoptogenic role at the mitochondria.

  2003cited by this paper
• BCL-xL and BCL2 delay Myc-induced cell cycle entry through elevation of p27 and inhibition of G1 cyclin-dependent kinases

  2002cited by this paper
• Bcl-2, via Its BH4 Domain, Blocks Apoptotic Signaling Mediated by Mitochondrial Ras

  2002cited by this paper
• Bcl-2 Overexpression in Human Melanoma Cells Increases Angiogenesis through Vegf Mrna Stabilization and Hif-1-mediated Transcriptional Activity

  2002cited by this paper
• Phosphorylation of Bcl-2 in G2/M Phase-arrested Cells following Photodynamic Therapy with Hypericin Involves a CDK1-mediated Signal and Delays the Onset of Apoptosis*

  2002cited by this paper
• Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics.

  2002cited by this paper
• BCL-x(L) and BCL2 delay Myc-induced cell cycle entry through elevation of p27 and inhibition of G1 cyclin-dependent kinases.

  2002cited by this paper
• Dynamics of expression of apoptosis-regulatory proteins Bid, Bcl-2, Bcl-X, Bax and Bak during development of murine nervous system

  2002cited by this paper
• The expanding role of mitochondria in apoptosis.

  2001cited by this paper
• Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas

  2001cited by this paper
• Rho Proteins: Linking Signaling with Membrane Trafficking

  2001cited by this paper
• Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

  2000cited by this paper
• BH4 domain of antiapoptotic Bcl-2 family members closes voltage-dependent anion channel and inhibits apoptotic mitochondrial changes and cell death.

  2000cited by this paper
• Association of insulin receptor substrate proteins with Bcl-2 and their effects on its phosphorylation and antiapoptotic function.

  2000cited by this paper

• Diffuse Large B-Cell Lymphoma/High Grade B-Cell Lymphoma with MYC and BCL6 Rearrangements: a study of 60 Cases.

  2025cites this paper
• Genetic correlation and causation of craniofacial microsomia with 33 diseases in Asian populations: insights from large-scale genome-wide cross-trait analysis

  2025cites this paper
• 13th Tuscany Retreat on Cancer Research and Apoptosis: Genetic profiling, resistance mechanisms and novel treatment concepts in cancer and neurodegeneration.

  2025cites this paper
• Integrated Network Pharmacology, Molecular Modeling, LC–MS Profiling, and Semisynthetic Approach for the Roots of Rubia tinctorum L. Metabolites in Cancer Treatment

  2025cites this paper
• Recent advances in canonical versus non-canonical Ca2+-signaling-related anti-apoptotic Bcl-2 functions and prospects for cancer treatment.

  2024cites this paper
• Combination of fruquintinib with venetoclax for the treatment of colorectal cancer

  2024cites this paper
• Advances in the treatment of relapsed/refractory marginal zone lymphoma

  2024cites this paper
• Incorporating mutational heterogeneity to identify genes that are enriched for synonymous mutations in cancer

  2023cites this paper
• Lymphoma in Border Collies: Genome-Wide Association and Pedigree Analysis

  2023cites this paper
• Metformin attenuates symptoms of osteoarthritis: role of genetic diversity of Bcl2 and CXCL16 in OA

  2023cites this paper
• MutSigCVsyn: Identification of Thirty Synonymous Cancer Drivers

  2022cites this paper
• In silico mutational analysis to identify the role and pathogenicity of BCL-w missense variants

  2022cites this paper
• BRCA1, BCL2, and the RB Tumor Suppressor have abnormal expressions in lung cancer

  2022cites this paper
• Barriers to achieving a cure in lymphoma

  2021cites this paper
• Transcript-Level Dysregulation of BCL2 Family Genes in Acute Myeloblastic Leukemia

  2021cites this paper
• Calcium-dependent signalling in B-cell lymphomas

  2021cites this paper
• O-GlcNAc Transferase Inhibitor Synergistically Enhances Doxorubicin-Induced Apoptosis in HepG2 Cells

  2020cites this paper
• Impact of lymphoma‐linked Asn11Tyr point mutation on the interaction between Bcl‐2 and a BH3 mimetic: Insights from molecular dynamics simulation

  2020cites this paper
• Docking‐based approach for identification of mutations that disrupt binding between Bcl‐2 and Bax proteins: Inducing apoptosis in cancer cells

  2019cites this paper
• Alterations of the pro-survival Bcl-2 protein interactome in breast cancer at the transcriptional, mutational and structural level

  2019influential citation
• The C/EBP Homologous Protein (CHOP) Transcription Factor Functions in Endoplasmic Reticulum Stress-Induced Apoptosis and Microbial Infection

  2019cites this paper
• Alterations of the interactome of Bcl-2 proteins in breast cancer at the transcriptional, mutational and structural level

  2019influential citation
• The interaction of Atg4B and Bcl‐2 plays an important role in Cd‐induced crosstalk between apoptosis and autophagy through disassociation of Bcl‐2‐Beclin1 in A549 cells

  2019cites this paper
• Hide or defend, the two strategies of lymphoma immune evasion: potential implications for immunotherapy

  2018cites this paper
• Expression of Bcl-2 is a favorable prognostic biomarker in lung squamous cell carcinoma

  2018cites this paper
• Nuclear factor-kappa B1 inhibits early apoptosis of glioma cells by promoting the expression of Bcl-2

  2017cites this paper
• AKT Axis, miR-21, and RECK Play Pivotal Roles in Dihydroartemisinin Killing Malignant Glioma Cells

  2017influential citation